Stage I-II low grade lymphoma: Prognosticators and treatment results
Abraham Kuten(Rambam Health Care Campus), Yossi Cohen, M. Leviov, Ron Epelbaum(University of Bern), Y Ben-Arie, David Faraggi(Carmel (Israel)), Menachem Ben-Shahar(Technion – Israel Institute of Technology), Nissim Haim(Technion – Israel Institute of Technology)
International Journal of Radiation Oncology*Biology*Physics
January 1, 1990
Cited by 0
Related Papers
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
|The Lancet|2002|1.7k
Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
|New England Journal of Medicine|1997|1.6k
Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer
|New England Journal of Medicine|2015|1k
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
|The Lancet Oncology|2010|944
Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
|Current Medicinal Chemistry|2009|480